Enterohemorrhagic Escherichia coli

Enterohemorrhagic Escherichia coli (EHEC) refers to a group of E coli species that cause severe bacterial infection, resulting in bloody dysentery and an increased risk of hemolytic uremic syndrome (HUS). The infection is seen worldwide across all age groups and requires prompt recognition and management to avoid complications, including long-term renal impairment. Serotype O157:H7 is the most well-recognized E coli strain responsible for global outbreaks of bloody diarrhea and HUS. The condition arises from the development of Shiga-like toxins that disrupt the intestinal cell membranes. This disruption leads to the loss of water and electrolytes, as well as the infiltration of inflammatory cells, which causes further cell injury. Complications include gastrointestinal and acute kidney injury, including HUS. Evaluation of EHEC infection typically involves identifying the presence of Shiga toxin-producing E coli in stool samples. Patients with suspected EHEC should be monitored for signs of HUS, especially in children. Management focuses on supportive care, including hydration and monitoring for renal complications, while antibiotics are generally avoided due to the risk of toxin release. This activity is designed for healthcare professionals to enhance proficiency in evaluating and managing EHEC infections. Participants will gain a deeper understanding of the condition’s etiology, risk factors, pathophysiology, presentation, and potential complications. Evidence-based diagnostic and therapeutic strategies will be highlighted. With increased competence, clinicians will be better equipped to collaborate within an interprofessional team caring for patients affected by this condition.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.